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Manipulation of cell death pathways has been identified as a common feature of host-microbe interactions.
We examine two examples: influenza A as a representative acute infection and cytomegalovirus as an
example of chronic infection. From the perspective of viral entry, replication, and transmission, we identify
points of interconnection with the host response to infection, namely the induction of host cell death, inflam-
mation, and immunity. Following from this analysis, we argue that the evolution and fine-tuned regulation of
death-associated genes may result from constant microbial pressure—past and present—that helped to
support and coordinate cell death programs within the host. Interestingly, the delay in host cell death allows
time for the virus to replicate while perturbations in cell death allow the host cell to initiate an immune
response. This may represent a genetically encoded trade-off ensuring survival of both host and virus, or
it may be a part of the complex agenda of infectious microbes.Precis
The interconnected pathways of programmed cell death are inti-
mately linked to the emergence of eukaryotic cells as well as the
evolution of multicellular organisms. Mitochondria, which play
a key role in programmed cell death in higher-order organisms,
derived from an endosymbiotic event, and the apparent ‘‘altru-
istic’’ suicide of cells for the good of the colony has been
observed in social unicellular organisms (e.g., Dictyostelium
discoideum). These events are punctuated by the emergence
of programmed cell death pathways and provide insight into
a cell-cell de´tente that predicates the intrinsic competition for
resources in a multicellular organism (Ameisen, 2004).
Similarly, we argue that host cell-microbe interactions may be
defined through their interdependent regulation of cell death
pathways. This may occur at the level of the infected cell, in
which for a finite period of time the fate of the microbe and the
host cell are joined. Microbe-induced host cell survival may
help to enhance its replication and dissemination within the
organism. Alternatively, the microbe may require the initiation
of cell death pathways in order to escape from the infected
cell. As a counterpoint, the host cell, although inherently inter-
ested in living, may respond to infection by activating pro-
grammed cell death, presumably aimed at clearing the patho-
genic microorganism. Dying cells may also impact host
immunologic responses. As such, understanding the regulation
of cell death pathways, induced either by host cell or microbe,
may require a deeper understanding of how noninfected cells
behave in response to their exposure to, and/or engulfment of,
infection-induced dying cells.
Herein, we examine the orchestration of cell death pathways
from the perspective of viral pathogenesis, which we identify
as the guiding force for host- microbe evolution: inducing and
modifying stress responses at the host cellular level, as well as
influencing downstream effects on the organism. Two detailed
paradigms are offered in order to examine different niches that478 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.have been occupied by viruses as their mechanisms of infection,
replication, and transmission intersect with cell death pathways:
(1) Acute viral infection, as represented by influenza A, will illus-
trate how different phases of infection demand opposing pres-
sures on apoptotic pathways in order to achieve efficient replica-
tion. Additionally, the modulation of autophagy and the crosstalk
between autophagic and apoptotic pathways are discussed in
light of their influence on host immune responses. (2) Chronic
viral infection requires distinct relationships with cell death
programs and we utilize cytomegalovirus (CMV) infection to
highlight the mechanisms by which some viruses have evolved
inhibitors of intersecting caspase-dependent apoptosis and
caspase-independent programmed cell death pathways. We
examine the emerging understanding of how cell death and
innate responses are integrated and review the balance that is
established between the virus and adaptive immunity during
latency. Although brief introductions are provided, we assume
prior knowledge of the molecular pathways of cell death (Green,
2011, in this issue of Immunity).
Starting Assumptions1. Host responses drive the selection of microbial variants.
By this we mean that microbes, intrinsic to their replicative
capacity and high rate of mutagenesis, possess the
genetic diversity to establish themselves within their
respective host. Achieving this includes securing their
niche through the avoidance of host defense; alternatively,
many organisms have adopted the strategy of co-opting
host stress pathways in order to support their replication
and transmission.
2. Our microbial adversaries have a shared interest in our
survival. Aware of the differential rate of mutagenesis
and evolution, Lederberg (2000) concluded that it is not
a Manichaean struggle between pathogen and host,
but instead a process of domestication to achieve
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‘‘a dead host is a dead end.’’ Lederberg continued by
arguing that ‘‘most successful parasites travel a middle
path. It helps for them to have aggressive means of
entering the body. but once established they also do
themselves (and their hosts) well bymoderating virulence’’
(Lederberg, 2000).
3. The evolutionary events in microbial genomes intersect
with programmed cell death pathways. By programmed
we mean active cell death as opposed to passive cell
death (Green, 2011). In positing this assumption, we aim
to integrate cell death into an evolutionary genetics
perspective (Barreiro and Quintana-Murci, 2010). In sharp
contrast to microbes, evolution of the host is slow. None-
theless, there exist evidence for microbes selecting for
genetically determined phenotypes—as first suggested
by Haldane, malaria-causing plasmodium species are
responsible for the prevalence of hemoglobinopathies in
African populations (Lederberg, 1999). We argue that in
formulating an association between cell death and immu-
nity, it will become evident that microbes have exerted
selective pressure on genetically encoded mechanisms
of host cell death.A Viral Perspective to Cell Death
Themicrobes’ agenda is assumed: transmission, infection, repli-
cation, and the readiness for future transmission. From an evolu-
tionary perspective, our agenda (as host) is the same. We
discuss two relationships, using representative microbial agents
responsible for acute and chronic infection in humans.
Acute Virus Infection—Influenza A
Influenza A virus (IVA) is a member of the Orthomyxoviridae
family; it is an enveloped virus with eight minus-sense RNA
segments that encode 11 viral proteins. It causes an acute infec-
tion in humans and is primarily transmitted fromperson to person
via exposure to micron-sized, virus-laden droplets that emerge
from the nose or throat of an infected person. Tropism is princi-
pally the bronchial epithelium (and for more virulent strains may
include the lower respiratory tract) and also includes immune
cells, with the latter having important implications for the host
response. Several phases of the viral life cycle can be delineated:
entry, replication, release, and transmission. Relevant to this
discussion is the fact that human influenza results in a complex
cytopathic effect (CPE) that is intertwined with the viral life cycle
and impacts innate and adaptive immune responses. Strikingly,
severe clinical disease is associated with an exaggerated host
response, including greater cellular infiltration into the infected
lung parenchyma (Kamps et al., 2006).
Inhibition of Apoptosis by IVA
As a result of viral entry and exposure to the viral genome,
several host pathways may be triggered. At the structural level,
this includes perturbation of the actin cytoskeleton, as well as
modulation of endocytic pathways by the IVA matrix protein 2
(M2) ion channel. Host sensors may also signal ‘‘danger,’’ espe-
cially once viral genomes begin to accumulate within the in-
fected cell. Depletion of nutrients and amino acids from the
intracellular environs and overproduction of viral proteinsprovide additional triggers for cell stress. All of these host
responses may suffice as inducers of programmed cell death.
Specific examples of entry and viral replication-induced death
include the activation of latent TGF-b, which results in the induc-
tion of endoplasmic reticulum (ER) stress and intrinsic apoptotic
cell death (Carlson et al., 2010; Schultz-Cherry and Hinshaw,
1996), and engagement of the intracellular host sensor RIG-I
by newly synthesized viral genomes, triggering type I interferon
(IFN) and in turn proapoptotic IFN-stimulated genes (ISGs) such
as protein kinase R (PKR) or tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL) (Herold et al., 2008). Although
the first newly produced viral particles may be detected within
5 hr after infection, the virus requires 10–12 hr in order to achieve
stable infection of the host. For these reasons, it is argued that
influenza actively interferes with apoptosis during the early
phase of infection.
Several lines of study have helped to establish a key role for
IVA nonstructural protein 1 (NS1) as an inhibitor of early
apoptosis. NS1 directly activates the phosphatidyl innositol
30OH kinase-(PI3K)-Akt signaling pathway (Ehrhardt et al.,
2007a; Ehrhardt et al., 2007b) (Figure 1), thereby inhibiting pro-
apoptotic factors such as caspase-3, caspase-9, and glycogen
synthase kinase-3B (GSK-3B), as well as stimulating antiapop-
totic Mdm2, X-linked inhibitor of apoptosis (XIAP), and NF-kB
signaling (Downward, 2004; Ehrhardt and Ludwig, 2009). NS1
is also capable of silencing RIG-I (Mibayashi et al., 2007) and
directly inhibiting PKR activity (Bergmann et al., 2000). By dimin-
ishing the induction of IFN production, NS1 may also impact the
kinetics of TRAIL-mediated apoptosis.
Induction of Apoptotis by IVA
Although cell survival may favor infection by providing additional
time for replication and assembly, it has been demonstrated that
caspase-3 activity is necessary for the release of viral ribonu-
cleoprotein (RNP) complexes from the nucleus and maturation
of haemagglutinin (HA) (Wurzer et al., 2003). Strikingly, it has
been demonstrated that inhibition of caspase-3 impairs IVA
propagation (Wurzer et al., 2003). Similarly, it has been reported
that inhibition of the proapoptotic effector Bax or overexpression
of the antiapoptotic Bcl-2 protein results in decreased viral yields
(McLean et al., 2009; Nencioni et al., 2009). In fact, IVA seems to
have evolved to delay apoptosis by inhibiting premature cell
death mediated by host cell stress responses, but actively
contributes to the induction of late-phase cell death (Zhirnov
and Klenk, 2007). This dichotomous effect of IVA on apoptosis
suggests that early induction of cell death may be a protective
response favoring viral clearance, whereas during the later
stages of the viral life cycle, cell death favors virus replication.
Regarding IVA proteins that directly articulate with cell death
effector proteins, one important example is PB1-F2, a recently
identified gene product that is encoded within an alternative
reading frame of the IVA polymerase gene, PB1(Chen et al.,
2001a). PB1-F2 contains a C-terminal mitochondrial targeting
sequence (MTS) and creates pores in planar lipid membranes,
which suggested a role in regulating intrinsic apoptotic cell death
(Chanturiya et al., 2004). Subsequent work has shown that
expression of PB1-F2 in the late phase of influenza A infection
(5–12 hr postinfection) contributes to IVA virulence in various
ways (McAuley et al., 2010). Supporting this argument, it has
been demonstrated that genetically ablating PB1-F2 expressionImmunity 35, October 28, 2011 ª2011 Elsevier Inc. 479
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Figure 1. Virus Entry and Replication Is
Interconnected with Cell survival and Cell
Death Pathways
After influenza A (IVA) entry, intrinsic cell stress
triggers host cell death pathways. An early phase
of viral protein expression results in a counterbal-
ance to the activation of apoptosis. NS1 expres-
sion activates PI3kAkt pathway, leading to survival
signals and the coincident downregulation of
proapoptotic factors (e.g., Caspase-3). Addition-
ally, autophagy enhances cell survival through the
removal of damaged cellular components and
through the direct inhibition of cell death. During
late phase of IVA infection, M2-mediated inhibition
of autophagosome maturation results in abortive
autophagy and increased cellular stress due
to accumulation of damaged organelles and
unfolded proteins. Moreover, PB1-F2 expression
triggers mitochondrial outer membrane per-
meabilization (MOMP) via a still disputed mecha-
nism that may involve Bax, VDAC, and/or ANT1.
This combination of events results in caspase
activation, which appears to facilitate maturation
and release of mature virions.
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imental models (Zamarin et al., 2006). Interpretation of in vivo
data, however, requires evaluation of many variables as different
cell types (e.g., epithelial cells and immune cells) may be differ-
entially susceptible to PB1-F2-induced cell death. It is interesting
to note that DF2 viruses did not show an altered viral replication
in Madine Darby Canine Kidney (MDCK) cells (Zamarin et al.,
2006), whereas a 50% reduction in monocyte apoptosis was
observed (Coleman, 2007).
Further characterization of the mechanism of cell death induc-
tion by PB1-F2 suggested a role for adenine nucleotide translo-
case 3 (ANT3) and voltage-dependent anion channel 1 (VDAC1)
interactions that resulted in release of cytochrome c (Cyt c) (Za-
marin et al., 2005). More recent results, however, indicate that
PB1-F2 activation of the intrinsic apoptotic pathway is depen-
dant on Bak- and/or Bax-mediated mitochondrial outer mem-
brane permeabilization (MOMP) (McAuley et al., 2010) (Figure 1).
One caveat of the latter study is that cell death assays were per-
formed with 27-mer peptides corresponding to the C-terminal
sequence of PB1-F2 as opposed to whole protein. An additional
confusion in the literature is the diversity of PB1-F2 genes that
exists—some variants possess proapoptotic functions whereas
others do not seem capable of mediating MOMP (Zell et al.,
2007).480 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.IVA and the Modulation of
Autophagy Is at the Crossroads of
Cell Survival and Cell Death
Cell stress and cell death pathways over-
lap as they share common triggers. As
a consequence, there has been in-
creasing attention to the crosstalk
between macroautophagic (a cell stress
and cell survival pathway) and apoptotic
pathways; for example, recent evidence
supports the existence of a complex
between the antiapoptotic protein Bcl-2
and the proautophagy regulator Beclin-1,thus coordinating reciprocal regulation of these two stress
pathways (Kang et al., 2011). We propose that during the early
phase of the viral life cycle, autophagic flux serves to promote
cell survival and inhibit apoptosis. This is supported by the simul-
taneous single-cell analysis of autophagy and apoptosis: func-
tional autophagic pathways delayed IVA-induced caspase-3
activation (de la Calle et al., 2011).
With respect to the late phase of replication, it has been
recently demonstrated that IVA infection results in autophago-
some accumulation as a result of M2-mediated inhibition of
autophagosome-lysosome fusion (Gannage´ et al., 2009) (Fig-
ure 1). Surprisingly, the mechanism responsible for the M2
blockade of autophagosome maturation is independent of its
proton channel activity and instead results from its modulation
of Beclin-1 (Gannage´ et al., 2009). Notably, the prolonged
expression of M2 results in abortive autophagy that leads to
the induction of apoptosis and eventually cell shrinkage and
engulfment by phagocytes (de la Calle et al., 2011; Uhl et al.,
2009; and unpublished data, M.L.A. and C. de la Calle). Interest-
ingly, M2 regulation of autophagy does not impact viral propaga-
tion (Gannage´ et al., 2009), yet additional experimentation may
be required to assess whether this holds for distinct cell types
(e.g., infected hematopoetic cells). In the context of the dichoto-
mous relationship between IVA and apoptotic programs, we
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Figure 2. Schematic Representation of the
Phases of Influenza Infection
Early phase influenza (IVA) infection is marked by
autophagy and inhibition of apoptosis. As a result
of dendritic cell (DC) infection, there is rapid acti-
vation of IVA-specific CD8+ T cells, but a subset of
this response (at least in experimental models)
appears to be counterprotective. During late-
phase infection, abortive autophagy and direct
action of IVA gene products coordinate the
induction of apoptotis. This contributes to
enhanced cross-priming, which favors the
expansion of protective CD8+ T cells. We propose
that the enhanced cellular immune response may
participate in the transmission phase by provoking
programmed reflexes such as coughing and
sneezing, thus spreading IVA.
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pathways; macro-autophagy, possibly induced by IVA infection,
facilitates cross-inhibition of premature apoptosis, yet at a later
time in the course of infection, M2-mediated inhibition of auto-
phagic flux (i.e., abortive autophagy) facilitates induction of
late-phase apoptosis (de la Calle et al., 2011; Rossman and
Lamb, 2009).
Taken together, these results suggest that influenza virus has
evolved an interconnected and intimate relationship with host
cell death pathways by specifically modulating the timing,
extent, and progression of apoptosis (Figure 2). As such, evalu-
ation of sequence polymorphisms in IVA NS1, PB1-F2, and M2
may be key to further understanding of strain-specific virulence
and disease pathogenesis. Furthermore, there appears to be
cell-type specificities in the balance between autophagy and
apoptosis induction underlying the importance to elucidate this
crosstalk in several cell types, but also in the context of the
host immune system.
Integration of Innate Immunity and Cell Death
Thus far, we have discussed themanner by which the host stress
response engages cell death pathways as a possible constraint
on viral replication; the other major barrier to transmission and
infection is the host immune response. But ‘‘barrier’’ is perhaps
not an accurate metaphor as microbes have identified numerous
strategies to go over, around and under these so-called immuno-
logic barriers. Instead, we consider it a node of integration and
emerging evidence indicates that the viral life cycle, cell stress,
and/or cell death pathways and host immunity are all intercon-
nected. For IVA infection, host sensors include pattern recogni-
tion receptors for single-stranded RNA (ssRNA): Toll-like
receptor (TLR)-7 and the retinoic acid inducible gene-I (RIG-I)
(Diebold et al., 2004; Kato et al., 2006). Both TLR7 and RIG-I
induce the production of proinflammatory cytokines, includingImmunity 35,type I IFNs. Although not reported for an
IVA model, we highlight that the TLR7
and RIG-I pathways also have in common
their being regulated by autophagic flux.
In the case of TLR7, it was demonstrated
by Iwasaki and colleagues that the
protein encoded by autophagy gene-5
(Atg5) is responsible for cytosolic ssRNA
being externalized, in a topologicalsense, exposing ligand to the luminal domain of TLR7 (Lee et al.,
2007) (Figure 3). In contrast, Atg5-Atg12 has been reported to
blunt RIG-I signaling by interfering with its recruitment of the
adaptor protein IPS-1 (Jounai et al., 2007). More direct evidence
has been suggested for RIG-I intersecting with cell death path-
ways: RIG-I recruits, via the adaptor protein IPS-1, the TNFR-
associated death domain (TRADD) protein, thus establishing
a molecular link with apoptotic effectors (Michallet et al., 2008)
(Figure 3). It remains to be determined how IVA-induced auto-
phagy regulates the activation of TLR7 or RIG-I pathways, and
furthermore, it should be explored whether the NS1 protein, or
for that matter the polymerase PB2, differentially modulates
RIG-I-induced IFN versus induction of cell death (Varga et al.,
2011).
In addition to the established host sensors for viral nucleic
acids, three independent studies have shown that IVA activates
the inflammasome, a distinct intracellular pathway that is linked
to inflammation and host immune responses (Thomas et al.,
2009; Allen et al., 2009; Ichinohe et al., 2009). In all studies, IVA
infection of caspase-1-deficient animals failed to induce IL-1b
or IL-18 secretion, resulting in enhanced susceptibility to infec-
tion. Notably, these initial studies do differ in their implication
of NLRP3 as the upstream trigger of inflammasome activation,
possibly a result of differences in the microbial flora present in
the different mouse colonies (Ichinohe et al., 2011).
Although distinct innate sensors seem to be independently
activated, they are in some cases integrated at the cellular and
transcriptional level. In the case of the inflammasome, activation
requires two signals with ‘‘signal 1’’ being mediated by TLR7,
which is both necessary and sufficient to induce transcription of
pro-IL1-b (Ichinohe et al., 2010). Remarkably, it is the IVA M2
protein that provides signal 2, acting this time via a mechanism
dependant on its pH-gated H+ channel activity. Specifically,October 28, 2011 ª2011 Elsevier Inc. 481
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Figure 3. Integrating the Effect of Influenza Viral Proteins on Endosomal and Cytosolic Innate Immune Sensors
During viral replication, single-stranded RNAmay be delivered to the endosome via the autophagy-mediated sequestration of cytosolic material, thus permitting
the engagement of Toll-like receptor 7 (TLR7). TLR7 in turn recruits Myd88, which results in the nuclear translocation of IRF7 and NFkB and the induction of type I
interferons and proinflammatory cytokines and/or chemokines, respectively. In the case of the latter, this response includes the expression of pro-IL1b and pro-
IL18 (signal 1 for inflammasome-mediated inflammation). Viral replication generates 50-ppp-genome that is recognized by RIG-I, an upstream sensor that recruits
IPS-1 to the mitochondrial outer membrane via a CARD-like domain and may inhibit Bcl2 antiapoptotic effects. Activation of IRF3 via TBK1- and IKK 3-dependent
phosphorylation results in expression of additional proinflammatory and antiviral host factors. IPS-1 also activates NFkB via FADD- and RIPK1-dependent
pathways with possible crosstalk to cell death pathways via caspase-8 and/or RIPK3 possibly leading to apoptosis or necroptosis. Production of M2 viral protein
inhibits autophagosomal maturation, thus having a potential effect on TLR7 and/or RIG-I. Additionally, M2 activates the NLRP3 inflammasome via a mechanism
dependent on its proton channel activity (signal 2). NLRP3 oligomerization activates caspase-1 via the adaptor protein ASC, resulting in the maturation and
secretion of Il1b and Il18. Caspase-1 may also induce pyroptosis, which has been reported to be inhibited by NS-1 via still unknown mechanisms.
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cation concentration (Ichinohe et al., 2010) (Figure 3). An impor-
tant and still open question is how the inflammasome is being
activated without inducing pyroptosis, a caspase-1 mediated
inflammatory cell death (Lamkanfi and Dixit, 2010). One possi-
bility is that the induction of prosurvival factors, perhaps induced
by the same signaling pathways, safeguard the cell from cas-
pase-1-mediated cell death. Alternatively, there may be new
secrets to IVA NS1 that await discovery. In fact, NS1 has been
reported to modulate inflammasome activation and caspase-1
maturation (Stasakova et al., 2005), however the dissection of
proinflammatory and pyroptotic effectors have yet to be clarified.
Death Is Not an Endpoint but the Beginning
of an Immune Response
As we move from interplay at the cellular level to integration at
the organism level, it has become evident that dying cells are482 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.important regulators of proimmune responses (Albert, 2004).
This is especially true when the dying cell harbors an infectious
microbe and/or has died a proinflammatory death (Green et al.,
2009). Prior work revealed a central role for apoptotic cells in
the delivery of antigen to conventional dendritic cells (cDCs) for
cross-presentation and activation of CD8+ T cells. Notably, the
initial studies employed an IVA infection model, after the transfer
of matrix 1 (M1) from infected donor cells to uninfected human
cDCs competent in presenting peptide epitopes derived from
M1 on major histocompatibility class I (MHC I) molecules (Albert
et al., 1998b; Albert et al., 1998a). More recently, it was sug-
gested that autophagic processes within the dying IVA-infected
cells are critical for achieving efficient antigen transfer and cross-
priming (Giodini and Albert, 2010; Uhl et al., 2009). Intriguingly,
M2-mediated inhibition may be central to these biologic path-
ways as inferred from the seminal observation that chloroquine,
Immunity
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enhance cross-priming (Accapezzato et al., 2005). Accordingly,
autophagy is not only integrating cell survival and cell death
pathways—it is also central to the coordination of immune
responses. Through the crosstalk between host stress and cell
death pathways, as well as innate programs triggered by IVA,
there is ample antigen and inflammation to support the establish-
ment of adaptive immune responses.
For a more complete perspective of the immune pressures ex-
erted on IVA during its life cycle, a brief interlude is required in
order to consider the cells that are insensitive to IVA-induced
cell death. Notably, mature cDCs, different from monocytes,
macrophages, or immature cDCs, resist the engagement of
apoptosis (Bender et al., 1998). As a consequence, IVA directly
infected mature cDCs provide a second source of proinflamma-
tory cytokines and presented antigen for the priming of T cell
responses. These two modalities for T cell priming (cross-
priming and direct priming) have been noted by Bennink and
colleagues, following the initial observations of the Doherty labo-
ratory. In C57BL/6 mice, infection with IVA/PR8 results in the
initial priming of two codominant populations of antigen-specific
CD8+ T cells: nucleoprotein (NP) and acid phosphatase (PA)-
specific responses (Andreansky et al., 2005). Although the NP
epitope (NP366–374) is broadly presented, due to its generation
being mediated by the conventional proteasome, PA epitope
(PA224–233) presentation is restricted to cells expressing the im-
munoproteasome (Chen et al., 2001b; Rivett and Hearn, 2004).
At first, many would conclude that regardless of the mode for
T cell activation, a robust CD8+ response should support viral
clearance. Surprisingly, this is not always the case. In a vaccine
study, Woodland and colleagues provided clear evidence that
a pre-existing NP366–374-specific CD8
+ T cell response favored
IVA clearance by limiting viral proliferation. This was in contrast
to pre-existing PA224–233-specific CD8
+ T cell responses, as
well as other subdominant T cell populations, which favored viral
replication via still undefined mechanisms (Crowe et al., 2006).
Integrating this information with knowledge about antigen
presentation pathways, we suggest that mouse adaptation of
the IVA/PR8 strain may have resulted in a ‘‘private conversation’’
between directly infected cDCs and PA224–233-specific CD8
+
T cells. Because epithelial cells do not express the immunopro-
teasome during early phases of cellular infection, they do not
process and present the PA224–233 epitope. In contrast, cross-
presentation favors the priming of NP366–374-specific CD8
+
T cells (Blache`re et al., 2005), which possess the ability to directly
engage an IVA-infected epithelial cell. Again, we find a temporal
relationship that follows the agenda of the microbe. Although we
recognize that peak viral production occurs prior to peak T cell
priming, it is possible that early adaptive immune responses
favor replication and extend the duration of viral shedding by al-
lowing the survival of mature cDCs. In contrast, late responses,
through the delivery of dying cell-associated antigen, help to
establish a so-called ‘‘protective’’ immune response (Figure 2).
Completing the Life Cycle
As discussed, the virus has evolved complex mechanisms to
modulate different forms of cell stress and cell death. Interest-
ingly, we identify a temporal control of apopotosis and auto-
phagy that maps to the different phases of the viral life cycle
and immune response. Likely, this is a pattern that can be foundin other acute infections. This pathophysiologic analysis of IVA
and cell death stimulates speculation that perhaps the establish-
ment of host immunity is also in line with the virus’ agenda for the
population (i.e., transmission). This would extend far beyond the
initial reflections of Lederberg (Lederberg, 2000). IVA may have
evolved to appropriate the adaptive immune responses initiated
by DCs dying cells—T cell influx into the lung may support sus-
tained inflammation that facilitates transmission (Figure 2). In this
view of viral infection, we can perhaps speculate that CD8+
T cells exert a host-induced apoptotic program (i.e., cytolytic
killing of target epithelium), which is initiated by viral antigen
cross-priming—all tuned to support the release of viral particles
into the airway during the transmission phase. It is exactly these
reflexes (cough, cough) that help to ensure exposure and infec-
tion of the next ill-fated host.
Chronic Virus Infection—Cytomegalovirus
The Herpesviridae family are a large group of double stranded
DNA (dsDNA) viruses that are divided in three subfamilies: alpha-
herpesviruses (e.g., HSV, VZV), betaherpesviruses (e.g., CMV,
HHV-6,7) and gammaherpesviruses (e.g., EBV, KSHV)(Arvin
et al., 2007). Most vertebrate hosts have been reported to harbor
at least one herpesvirus infection and interestingly, there is strict
species specificity with most transmissions being a result of
either vertical (less common, with the exception of CMV) or hori-
zontal spread. This suggests an extensive history of coevolution
between virus and host, arguably with the virus having evolved to
exploit a unique niche within their susceptible host. With respect
to human herpesviruses, all have in comment that release of
infectious progeny is accompanied by destruction of the infected
cell, referred to as CPE, and all possess the potential to enter
a state of latency within their natural host. Human herpesviruses
are widespread in the population and cause mostly benign acute
infection followed by an imperceptible chronic, latent-phase
infection. Nonetheless, at-risk individuals (e.g., persons with
acquired or congenital immunodeficiencies) may develop severe
disease (Arvin et al., 2007). Among the herpesviruses, cytomeg-
aloviruses (CMVs) have been highly studied as a model of viral
inhibition of cell death and immunity (Brune, 2011; Hengel
et al., 2005). CMV replicates in many differentiated cell types in
the host and its cell cycle is divided into three phases: immediate
early (IE), delayed early (DE), and late (L). The replication cycle is
relatively slow, with a switch from the IE to L stages occurring
after 24 hr. An additional 24 hr is required for the production of
infectious virions and peak viral titers are not reached until
several days postinfection (Arvin et al., 2007). Thus CMV must
regulate cell death, even during the lytic state of infection.
Although we have included data from mouse and human CMV
infections (MCMV and HCMV, respectively), we are aware and
offer as a caveat that because of species specificity, some of
the mechanisms are not shared between these two viruses.
Regulation of Cell Death during Lytic CMV Infection
Cytomegaly, or cellular swelling, is a hallmark feature of CMV
infection. This unique CPE can be first observed as early as
a few hours postinfection and has been attributed to its rapid
activation by CMV of host pathways. NF-kB activation has
been observed within 5min after exposure of cells to virus (Poole
et al., 2006); CMV glycoprotein B (gB) binding can trigger the
activation of phospholipases C and A2 as well as an increaseImmunity 35, October 28, 2011 ª2011 Elsevier Inc. 483
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Figure 4. Cytomegalovirus Entry Results in
the Reprogramming of Multiple Cell Death
Programs
Cellular infection by cytomegalovirus (CMV)
results in a rapid activation of inflammation and
stress pathways. The latter engages BH3-only
proteins and establishes a pro-apoptotic pressure
on the host cell. Counterbalancing these stimuli,
CMV encodes for specific inhibitors for Bax acti-
vation, referred to as viral mitochondrial localized
inhibitor of apoptosis (vMIA), and, in the case of
mouse CMV, an viral inhibitor of Bak oligomeriza-
tion (vIBO). Inflammation also engages extrinsic
pathways for apoptosis. The viral inhibitor of cas-
pase activation (vICA) serves to inhibit caspase-8
protease activity, but has the consequence of
simultaneously sensitizing the cell to necroptosis.
Hence, a fourth regulator of cell death (to date
identified in mouse but not human CMV), the viral
inhibitor of RIPK activation (vIRA), perturbs RIPK1
and RIPK3 interaction via its RHIM domain.
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context of an infectious process, engagement of TLR9 in nonin-
fected plasmacytoid dendritic cells (pDCs) results in the produc-
tion of type I IFNs (Dalod et al., 2003). To blunt such activation,
CMV has evolved to express immediate early (IE) gene products
that reprogram the host response, including the regulation of
NF-kB, interferon response factor 3 (IRF3) complex formation,
and IFNa/b (IFNAR) receptor signaling (Arvin et al., 2007).
Although successful at rapidly regulating these host programs,
proapoptotic signals are abundant as CMV enters the nucleus,
triggers host cell DNA damage, initiates an abortive cell cycle,
modifies the ER, alters mitochondrial function and activates
PKR (to name a few early events) (reviewed elsewhere, Tait
and Green, 2010). Here, we focus on the viral encoded mecha-
nism that perturbs different death pathways during the lytic
phase of infection.
HCMV and MCMV both encode viral inhibitors of intrinsic and
extrinsic apoptosis during the early phase of infection. In the
case of HCMV, there exist two genes, ul37x1 and ul36: the
former encodes for and will be referred to as the viral mitochon-
drial localized inhibitor of apoptosis (vMIA), and the latter
encodes the viral inhibitor of caspase 8 activation (vICA). In addi-
tion, the major IE gene products IE1p72 and IE2p86 participate in
the inhibition of death receptor-induced apoptosis; however, the
precise mechanisms remain unknown (Brune, 2011). MCMV
encodes several known inhibitors of apoptosis. These include:
(1) a homolog of vICA, the gene product of m36; (2) a positional
and functional analog of vMIA, encoded by the gene product of
m38.5; and (3) a unique regulator of apoptotic cell death en-
coded bym41.1, generating a gene product called viral inhibitor
of Bak oligimerization (vIBO).
Functionally, vMIA expression results in the translocation of
Bax from the cytosol to the mitochondrial membrane, suggest-
ing that vMIA sequesters oligomerized high molecular weight484 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.Bax in an inactive conformation, thereby
inhibiting MOMP and subsequent
intrinsic apoptotic cell death (Arnoult
et al., 2004) (Figure 4). As indicated
above, MCMVm38.5 also sequesters oli-gomerized Bax at the mithochondria, but is not homologous to
the HCMV ul37x1 gene product. Importantly, D38.5 MCMV
shows enhanced viral induced apoptosis (Jurak et al., 2008).
This observation illustrates the nonredundant role for Bax oligo-
merization in the CMV life cycle.
In addition to its role in inhibtion of host-induced apoptosis,
vMIA might have a role in inhibiting CMV-mediated programmed
cell death (cmvPCD), an hCMV-specific caspase-independent
cell death pathway linked to intramitochondrial accumulation
of the pro-death effector protein Omi (also known as HtrA2)
during the late phases of infection (McCormick et al., 2008).
cmvPCD timing seems to be tightly regulated by vMIA expres-
sion, independent of its function in regulating apoptosis. Via
a still unknown mechanism, vMIA delays cmvPCD, which is
believed to extend the period of viral production by infected
cells, potentially increasing transmission. Additionally, the broad
expression of Omi in mammalian cells and the fact that Omi-
overexpressing cells only die when infected suggested that
this pathway may represent a process of viral de´tente, defining
the timing of cell death in a manner that is in accord with the viral
agenda. This interplay between host and direct viral-induced
cell death pathways is reflective of the complex relationship
described for IVA.
It has recently been characterized that MCMV also encodes
a vIBO. Specifically, m41.1 is a mitochondrial targeted protein
capable of sequestering oligomerized Bak (Cam et al., 2010)
(Figure 4). While Dm41 MCMV has a striking death phenotype,
its effect on viral replication is restricted to macrophage infection
(Brune et al., 2003). This provides an interesting parallel to the
differential effects on cell death by IVA gene products. As an
additional point, it is interesting to note the distinct strategy
that has evolved in betaherpesviruses, which (at least for rodent
CMVs) employ two distinct proteins in order to influence intrinsic
cell death. This is in contrast to gammaherpesviruses as well as
Immunity
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double as inhibitors of both Bak and Bax (Lagunoff and Carroll,
2003). Perhaps the distinct mechanisms of regulation in CMVs
permit the virus’s ability to evolutionarily tune its modulation of
intrinsic apoptosis across several host cell types.
In order to modulate extrinsic cell death, betaherpesviruses
encode a conserved vICA. Although its evolutionary conserva-
tion suggests an important role in viral infection and dissemina-
tion, vICA expression is considered dispensable for the HCMV
life cycle and in MCMV shows a growth phenotype restricted
to macrophages (Cicin-Sain et al., 2008; McCormick et al.,
2005; McCormick et al., 2010; Me´nard et al., 2003; Skaletskaya
et al., 2001). This may indicate that CMV-infected macrophages
are particularly sensitive to death receptor-mediated cell death.
As a result, the survival advantage conferred by vICA expression
seems to act by inhibiting the death of macrophages, a poten-
tially important cell type for dissemination within the infected
host (Ibanez et al., 1991). vICA binds to the prodomain of cas-
pase-8 and prevents its oligomerization and cleavage (Skalet-
skaya et al., 2001) (Figure 4). Although vICA may be considered
mechanistically similar to viral caspase-8 inhibitors (v-FLIP),
CMV has again evolved a distinct molecular solution—vICA
shares no evident homology to death effector domains typical
of this class of apoptosis inhibitors (Skaletskaya et al., 2001).
Recently, it has become evident that in the absence of cas-
pase-8, cells become susceptible to programmed necrosis
(also referred to as necroptosis) (Kaiser et al., 2011; Oberst
et al., 2011). This pathway is mediated by the receptor interact-
ing protein kinase (RIP) homotypic interaction motif (RHIM)-con-
taining signaling adaptors RIP1 and RIP3. Strikingly, Mocarski
and colleagues demonstrated that MCMV, through its expres-
sion of vICA, sensitizes cells to RIP3-mediated necroptosis (Iba-
nez et al., 1991; Upton et al., 2010); however, the virus (high-
lighting its prior knowledge of this pathway) has evolved to
express a viral inhibitor of RIP activation (vIRA), encoded by
m45. MCMVm45 was first described as being required for repli-
cation and cell death inhibition in endothelial cells, with a notable
impact on in vivo viral propagation (Brune et al., 2001). It has now
been demonstrated that vIRA inhibits RIP1 and RIP3 interaction
through its viral RHIM domain (Rebsamen et al., 2009) (Figure 4).
Remarkably, in vivo infection of T and NK cell-deficient mice
with MCMV engineered to express a RHIM-domain mutant
m45 (m45mutRHIM) resulted in a 7-log reduction in salivary
gland viral titers (Upton et al., 2010). Although RIP3 expression
is required in order for MCMV to sensitize cells to RIP3-mediated
necroptosis, it is unclear what cellular infections (e.g., fibro-
blasts, endothelium or macrophages) account for this dramatic
phenotype. Additionally, the processes leading to RIP3 activa-
tion remain unknown. One possibility is via TLR3 or the DNA
sensor AIM2 (discussed below). Notably, these pathways
engage RIP3 and they too are abrogated by vIRA expression
(Mack et al., 2008). What is clear is that the crosstalk between
cell death and proinflammatory pathways is again an area
where we have much to learn from the study of the CMV life
cycle. The observation that macrophages (and other RIP3-
expressing cell types) are particularly sensitive to infection by
several genetically ablated strains (m41.1,m45) puts pronecrotic
adaptors as central regulators of cell fate (Brune et al., 2001;
Mack et al., 2008).Integration of Innate Immunity and Cell Death
CMV has a long-term interest in the occupation of secure niches
within its host. Given the initial impact on host cell signaling path-
ways and the profound effect on cellular metabolic function, it is
almost self-evident that ‘‘danger’’ signals will be triggered, both
by microbial-associated and damage-associated molecular
patterns (MAMPs and DAMPs, respectively) (Mackey and
McFall, 2006; Seong and Matzinger, 2004). To counterbalance
host responses, CMVs have evolved various strategies,
including the expression of viral cytokines and chemokines,
decoy receptors, enzymatic proteins capable of altering the
function of host immune proteins, modulators of bioactive lipid
and carbohydrate effectors, and inhibitors of innate and adaptive
signaling pathways. Thorough analysis of how CMVs regulate
immune responses can be found elsewhere (Miller-Kittrell and
Sparer, 2009); here, we focus on those pathways for which there
exists evidence of crosstalk with cell death.
TLR1, TLR2, TLR3, TLR9, and DAI (also known as ZBP1) have
been reported as host sensors of CMV infection and replication.
Interestingly, these four sensor pathways offer examples of
direct and indirect crosstalk with cell death pathways. TLR1
and TLR2 heterodimers are engaged by and has been shown
to coimmunoprecipitate with HCMV gB and glycoprotein H
(gH) (Boehme et al., 2006). It has also been reported that
R753N TLR2 polymorphisms confer susceptibility to higher
HCMV load, as reported in a small cohort of liver transplant
recipients (Kijpittayarit et al., 2007). Moreover, experimental
evidence in mice indicate that TLR2-deficient strains have higher
liver and splenic MCMV titers, which could be explained by
diminished natural killer (NK) cell activation (Szomolanyi-Tsuda
et al., 2006). Although it has yet to be firmly established in amodel
of CMV infection, it has been suggested that apoptotic pathways
may be directly induced as a result of TLR2 activation. For
example, there exists evidence for extrinsic apoptosis, demon-
strated by the in vitro exposure of HCMV to syncytiotropho-
blasts, which produce TNF-a as a result of TLR2 activation,
inducing apoptosis in neighboring cells (Tomkinson et al., 2010).
Less is known about the mechanisms by which CMV compo-
nents (presumably nucleic acids) engage TLR3 and TLR9. TLR3
is engaged by dsRNA, and it has been suggested that such
ligands might be generated as a consequence of bidirectional
transcription during the CMV life cycle (Tabeta et al., 2004). Still
unknown is how such dsRNA would gain access to the ligand
binding domain of TLR3. It has been shown that Tlr3/ mice
are hypersusceptible to MCMV infection (Tabeta et al., 2004).
This mechanism requires additional study, however, given that
this phenotype seems dependant of the titer of viral inoculation
(Edelmann et al., 2004). Regardless of the impact on host pheno-
type, the engagement of the adaptor protein TRIF by TLR3
provides an exciting link to necroptosis. It has been known for
some time that in contrast to other TLRs, which use interleukin
1 receptor-associated kinase (IRAK) proteins to activate
NF-kB, TLR3 activation of NF-kB is dependant on RIP kinases
(Feoktistova et al., 2011; Meylan et al., 2004). More recently,
evidence has been provided that TLR3 activation can result in
assembly of the so-called ‘‘ripoptosome,’’ which contains
RIP1, Fas-Associated protein with Death Domain (FADD), cas-
pase-8, and caspase-10 (Feoktistova et al., 2011), and under
specific conditions may result in necroptosis. Through anImmunity 35, October 28, 2011 ª2011 Elsevier Inc. 485
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via an IRF-3-mediated signaling pathway. It has been revealed
that IRF-3 contains a BH3 domain that enables interaction with
Bax, that mediates their colocalization to the mitochondria,
and that is essential for the induction of MOMP (Chattopadhyay
et al., 2010). Future studies will be required to define the parti-
tioning of IRF-3-induced cell death versus activation of type I
IFN pathways. For TLR9 activation, CMVmay engage an indirect
cell death mechanism because the dominant cell type express-
ing this host sensor is not directly infected (Dalod et al., 2003;
Krug et al., 2004). As discussed above, this includes the rapid
induction of TNFR superfamily members that engage death
receptors and activate caspase-8. Presumably, these rapidly
induced innate pathways explain the evolutionary conservation
of the IE gene product vICA across betaherpesviruses.
Considerable advances have been made toward the charac-
terization of DNA sensors and two molecules have been thus
far implicated in CMV pathogenesis. Interestingly, here too,
crosstalk with cell death pathways has been elucidated as well
as the demonstration of CMV-encoded regulators. HCMV
genome engages the DNA-dependent activator of IRFs (DAI,
also known as Z-DNA binding protein 1 or ZBP1) and on the
basis of studies using UV-inactivated virus, it has been sug-
gested that genomic dsDNA, during its transport to the nucleus,
is recognized by host sensors (DeFilippis et al., 2010). In addition
to IRF-3 activation, DAI may also recruit RIP1 and RIP3 through
its two RHIM domains (Rebsamen et al., 2009). This provides
a mechanistic link to NF-kB activation, but may also engage
the ripoptosome. Importantly, MCMV m45 has been reported
to inhibit DAI signaling. One study has implicated a second
DNA sensor, absent in melanoma 2 (AIM2), that creates a link
to the inflammasome. Mice deficient for AIM2 showed a mild,
but significant enhancement in viral propagation and diminished
IFN-g production in NK cells (Rathinam et al., 2010). Although
a clear link between AIM2 activation and pyroptosis has been
established in other infectious models (e.g., Listeria monocyto-
genes), it remains unclear whether caspase-1-mediated cell
death contributes to CMV pathogenesis. What is clear is that
during the early phases of infection, CMV has evolved a mecha-
nism for modulating multiple cell death and innate immune path-
ways. Studies on single cells with kinetic resolution will be
required to precisely establish the temporal regulation of these
pathways as it maps to viral antigen expression.
A ‘‘Death-Defying’’ Balancing Act between Viral
Propagation and Cellular Immunity
Given the mechanisms discussed thus far, it is no surprise that
CMVs have evolved strategies for redirecting normal cellular
pathways implicated in cell-mediated immunity. What is sur-
prising, however, is that in spite of redundant mechanisms of
escaping detection, there exist long-lasting and robust T cell
responses. Many in-depth reviews have been devoted to
CMV-mediated inhibition of NK and T cell activation and is there-
fore not discussed here (Loureiro and Ploegh, 2006; Mocarski,
2004). Instead, we focus on the role of direct versus cross-
priming of T cells in the context of CMV-specific immunity.
Because of the obvious challenges of studying functional
immune activation in humans, most studies of T cell priming
have been performed with MCMV. Given that DCs may be
directly infected by CMV, viral protein destabilization of key486 Immunity 35, October 28, 2011 ª2011 Elsevier Inc.antigen-processing machinery might impact priming efficiency.
In one important example, MCMV m152 (gp40) was shown to
be capable of retaining peptide-loaded MHC I complexes in
the cis-Golgi, and in vivo data suggest that Dm152 MCMV was
more rapidly cleared (Holtappels et al., 2004; Ziegler et al.,
2000). Strikingly, clearancewasmediated bym45985-993-specific
Db-restricted CD8+ T cells, which was considered the immuno-
dominant response during acute infection, and presumably
primed via cross-presentation of antigen acquired from dying
cells. This observation led to the conclusion that in some
instances MCMV ‘‘misleads’’ its host by facilitating the priming
of CD8+ T cells specific for an epitope that is not efficiently pre-
sented by directly wild-type-infected cells (Holtappels et al.,
2004). These data highlight an interesting parallel to IVA adaptive
responses. Another intriguing point is that the population of im-
munodominant T cells in mice was reactive to a peptide present
in vIRA. This illustrates a potential trade-off between inhibition of
necroptosis and exposure of high-affinity T cell epitopes, which
in turn must be retained within infected cells by other MCMV
regulatory proteins (e.g., m152). Future studies will be required
in order to clarify the balance between viral inhibitors of cell
death, antigen presentation, and modulators of CMV immunity.
Inhibiting Cell Death during Latent Infection
Herpesviridae share the ability to enter an altered transcriptional
and translational state in the course of their viral life cycle. This
state of latency is defined as a nonproductive, persistent infec-
tion, in which the viral genome is present, but gene expression
is restricted to a smaller subset of genes, and importantly, infec-
tious virus cannot be detected. Studies in humans andmice have
identified endothelial cells and selected cell types of the myeloid
lineage as critical sites of CMV persistence and latency.
Although latent HCMV has the potential to become reactivated
and has been implicated in several human diseases, we are
only beginning to understand the virally encoded determinants
and their role in establishing and maintaining CMV latency.
This is in sharp contrast to other herpes viruses, such as EBV,
in which clearly established latency programs as well as links
to cell death pathways have been defined (e.g., viral Bcl-2) (Virgin
et al., 2009). Investigation into CMV latency has been con-
founded by the species specificity of HCMV and the low fre-
quency of latently infected cells. The establishment of latent
infection is by definition closely linked to host immune responses
and implicates an interconnection with cell survival and cell
death pathways. Therefore, greater attention to CMV latency is
warranted.
Microarray studies of gene expression during HCMV latency
phase have provided some initial insight into the restricted
expression of viral proteins. Human cytomegalovirus latency
associated transcripts (CLTs) are thought to include gene prod-
ucts encoded in the major immediate early (MIE) and UL111A
regions. One interesting latency gene is US28, a functional che-
mokine receptor that binds to a subset of CC chemokines (Slo-
bedman et al., 2010). Notably, US28 induces caspase-8 and
caspase-10 activation, resulting in apoptotic cell death.
Although the precise mechanism of oligomerizing these initiator
caspases is unknown, it does not seem to involve classical death
receptor engagement (Casarosa et al., 2001).
Forging a link between CLT-induced cell death and host
immunity may establish a deeper understanding of latency itself.
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in immune competent hosts, is punctuated by intermittent viral
reactivation. During MCMV latency, stochastic episodes of desi-
lencing (or reactivation) have been linked to the transient gener-
ation and presentation of viral peptide epitopes byMHC I (Simon
et al., 2006). Such transient events may also serve to maintain
the robust T cell activation, at least for a subset of CMV-specific
T cells (Munks et al., 2006). Of great interest will be the mapping
of which cells experience transient reactivation and how these
events are linked to antigen production, cell death, and cross-
priming. Characterization of these re-activation episodes will
alter our concept of latency, which may be erroneously associ-
ated with the absence of detectable virus because of the insen-
sitivity of our assay systems. In this regard, the immune system
and the engagement of cell death programsmay provide a better
definition of what constitutes a latent infection. Finally, this anal-
ysis offers an opportunity to consider the relationship between
viral transmission and orchestrated bouts of CMV reactivation.
Indeed, the epithelium within the salivary gland has provided
an interesting example of distinct cell-specific regulation.
HCMV DNA may be detected in the saliva of 2%–10% of the
human population at any interval time (Britt, 2007). A link to
immune regulation is evident, as suggested by studies in iatro-
genic-induced immunosuppression in which shedding rates
can reach 45% in patients after stem cell transplantation (Cor-
reia-Silva et al., 2007). Other target tissues in which shedding
and transmission have been described are the ductal epithelium
of mammary glands (accounting for mother to child infection);
the ductal epithelium of the kidney tubules (accounting for shed-
ding in urine); and the syncytiotrophoblasts (accounting for
transplacental transmission). As such, the intermittent relaxation
of antigen presentation and T cell priming may all be part of the
plan—controlling host immunity and providing ample opportu-
nity for induction of cell death and widespreadmicrobial dissem-
ination (Figure 2).
Although hardly exhaustive, our examination of viral pathogen-
eses has illuminated interesting differences between IVA and
CMV with respect to their molecular articulation among viral
entry, replication, transmission, and the pathways of cell death
and immunity. Even in the comparison between HCMV and
MCMV, we observe striking distinction in how the viruses have
coevolved with their respective hosts. Nonetheless, in the exam-
ples provided, we see an important commonality in the delayed
host cell death, which may favor the virus, whereas the conse-
quent perturbations in cell death might serve as a sensor for
the host cell to initiate an immune response. This may represent
a genetically encoded trade-off ensuring mutual survival, or we
may discover that it is all part of the complex agenda of immuno-
logically niche-filling infectious microbes (Hedrick, 2004).
Cell Death as a Window into Coevolution
The study of disease pathogenesis from the perspective of cell
death provides interesting insight into host immunity, and it
may provide a mechanism to chart a historical record of our
coevolution with a particular microbe or class of microbes (de-
pending on the rate of evolution). Recent studies have applied
such approaches for the examination of host sensors, discov-
ering that in the human population, there is evidence of genetic
constraint on TLR3, TLR7, TLR8, and TLR9 that is distinct fromthe observation of genetic drift within TLR1, TLR2, TLR4,
TLR6, and TLR10. This observation suggest the possibility that
though their interactions with the class of endosomal TLRs,
viruses are exerting selective pressure on their host; in contrast,
there appears to be a redundancy in the latter class of TLRs with
other host sensors playing perhaps a more critical role. Defining
the cell survival and cell death genes under evolutionary
constraint will provide a similarly rich account of past infections
and may provide further insight into the complex crosstalk
among microbe, cell death, and immunity. Influenza in this
context would provide an interesting evolutionary model as it is
possible to track the emergence of new IVA genomes, with
human data regarding the respective virulence of seasonal,
epidemic, or pandemic viral strains. Spanning a different evolu-
tionary timeline and involving multiple microbe-vertebrate host
relationships, the family of herpesviruses will provide a unique
opportunity.
One striking observation is the temporal and apparently
dichotomous relationship that governs themicrobe’s connection
to host cell death. The counterbalanced induction and inhibition
of cell death provides a striking example of ‘‘genetic addition’’—
a selfish gene’s strategy that creates the foundation for symbi-
otic relationships and speciation (Ameisen, 2004; Mochizuki
et al., 2006). Classically stated, a gene or gene complex capable
of achieving genetic addition encodes a toxin (e.g., inducer of
cell death) and an antitoxin (e.g., inhibitor of cell death). The anti-
toxin may act directly on the toxin, with temporal regulation or
differential kinetics of decay ensuring an addicted state. Alterna-
tively, the antitoxin can act via host pathways that crosstalk with
the effector mechanism of toxin-mediated cell death. Moreover,
as suggested herein, the relationshipmay bemulticellular, acting
across the host immune response to counterbalance the activi-
ties of antitoxin and toxin on host physiology.We have previously
speculated that the answer to the question of ‘‘Why cell death?’’
might be phagocytosis. This was first suggested by Charles
David and was based on the discovery that the metazoan Hydra
vulgaris survives in nutrient-deprived conditions by capturing
energy from internalized apoptotic epithelial cells, a survival
mechanism that was recently shown to also implicate autophagy
(Chera et al., 2009). These intriguing studies suggest that phago-
cytosis might have preceded the evolution of apoptosis, with
energy conservation having offered the selective advantage for
communal single-celled organisms to evolve mechanisms of
programmed cell death (Albert, 2004). Recent evolutionary
studies of ancestoral eukaryotes (e.g., Thermoplasma) indicate
that it might have been a trifecta—phagocytosis, eukaryogene-
sis and perhaps intrinsic apoptosis—all emerging as part of the
evolutionary continuum associated with the acquisition of
a bacterial endosymbiont (Yutin et al., 2009). Coming back to
our interconnectedness with viruses (and transposable ele-
ments), we acknowledge the contributions made in the form of
telomeric ends to our DNA (Nosek et al., 2006), the emergence
of genes mediating somatic recombination in lymphocytes (Fug-
mann, 2010), and the possible role of transposable elements in
miotic segregation (Arkhipova and Meselson, 2005). When all
is said and done, we as academics may not only be learning
about cell death pathways from our microbial counterparts, we
may have actually evolved the mechanisms themselves as
a direct response to viruses’ dying need to replicate.Immunity 35, October 28, 2011 ª2011 Elsevier Inc. 487
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